The in vitro antibacterial activity of the anthelmintic drug oxyclozanide against common small animal bacterial pathogens.

CONCLUSION AND CLINICAL IMPORTANCE: Oxyclozanide demonstrated in-vitro antibacterial activity against meticillin-resistant S. pseudintermedius. Further studies are needed to evaluate the potential use of oxyclozanide as a topical bactericidal agent. PMID: 31062461 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31062461?dopt=Abstract

Source: Veterinary Dermatology - May 6, 2019 Category: Veterinary Research Authors: Levinson MR, Blondeau JM, Rosenkrantz WS, Plowgian CB Tags: Vet Dermatol Source Type: research